Xueba's life simulator

Chapter 230 The Business of Offending People
"Dean Gan, hello."

After knowing from his mother that his cousin Song Lina wanted to undergo myopia surgery, Zhou Ming found the one he was looking for now.

"Professor Zhou, sit down." Zhou Ming called Dean Gan, who was wearing a white coat at this time.

This Dean Gan is named Gan Yuntao, and he is the dean of the Eye, Ear, Nose and Throat Hospital of Sinian University, also known as the Hospital of Five Senses in Shanghai. Member of the Cornea Group and Optometry Group of the Chinese Academy of Ophthalmology, the leader of the Ophthalmology Group of the Laser Society of the Magic City Medical Association, and the leader of the Optical and Refractive Surgery Group of the Magic City.

It can be said that he is the top expert in the field of myopia in China and even in the world.

Zhou Ming came to him this time, in addition to wanting to know more about myopia surgery for Song Lina's affairs, another purpose was that he really wanted to let future biotechnology companies set foot in the field of myopia.

Whether it's for Song Lina's affairs or the future biotechnology company's affairs, Zhou Ming needs to have a clearer understanding of myopia surgery.

It may take a few years for future biotechnology companies to set foot in the field of myopia, and rely on future organ cloning technology and artificial intelligence technology to replace eyeballs or electronic eyes.

What Zhou Ming hopes is that in the past two years, future biotechnology companies will be able to come up with a technology that can surpass the existing myopia surgery field.

Although Zhou Ming now knows a lot about myopia and myopia surgery, he is not specialized in this area after all. Even when he used the life simulator to simulate before, he had never really engaged in it in the simulated world. I have done research in this area, and at most I have learned some knowledge in this area.

What exactly is the research on myopia in this era, Zhou Ming needs to ask experts in this field.

Last year, a foreign institution ranked global experts in the field of myopia based on the number of published papers and publications. In this ranking, Gan Yuntao, whom Zhou Ming is now looking for, is the eighth in the world. It is also number one in the country.

This shows its strength in the field of myopia.

"I'm in the hospital now, and you came to see me mainly because of myopia surgery, so you don't need to call me Professor, just call me Dr. Gan." Gan Yuntao said to Zhou Ming.

Like Ren Le, Zhou Ming had told Gan Yuntao in advance when he came to see Gan Yuntao this time, and the time and place to meet now were also determined by Gan Yuntao and Zhou Ming in advance.

Since Zhou Ming told Gan Yuntao before that he came to see him about myopia surgery, the place where Gan Yuntao and Zhou Ming met was also the hospital where he worked. Zhou Ming introduced.

"Then let me just say it directly. I want to know more about the field of myopia, especially the research in this area in recent years." Zhou Ming said to Gan Yuntao.

"I have made some preparations in advance, so I will talk about this field with Professor Zhou from the beginning, and then I will talk to you in detail about the research in this area in recent years. What do you think?" Gan Yuntao said to Zhou Ming.

Although Zhou Ming is only in his 20s, Gan Yuntao, a doctor of medicine, has heard of Zhou Ming's name for a long time.

After Zhou Ming contacted him before and said that he wanted to come to him and talk to him about myopia, Gan Yuntao, who is 49 years old and 25 years older than Zhou Ming, even felt a little flattered.

There is no way, whoever called Zhou Ming would go to the official channel every now and then and be praised by the official, or he would research it quietly and get an award along the way.

At home and abroad, many scholars in the field of biology and mathematics always inquire about the projects carried out by Zhou Ming and his experimental groups and the experimental department of the future biotechnology company before conducting a certain research. They are afraid of colliding with them. .

If a car crashes, they are most afraid that their project has not been started for a long time, and other people have already produced better results than they expected.

Gan Yuntao has heard of this situation more than once or twice, whether in the field of mathematics or biology.

In Aurora University, which was located in Shanghai before, some graduate students majoring in mathematics and biology were forced to change their graduation subjects because of this, passively extending the graduation time, which is really a bit miserable.

"It's okay with me. Doctor Gan can say whatever he wants." Zhou Ming said.

Soon, Gan Yuntao and Zhou Ming talked about myopia, including myopia surgery.

"...Therefore, because myopia surgery has been around for too short a time, it is not clear whether there will be more serious sequelae when you get older. We can only wait for the first batch of myopia surgery to get old. Only then will we know.

But when the first batch of myopia surgery patients get old, the technology of myopia surgery at that time may be very different from when the myopia surgery first came out. It must be unreasonable to see whether myopia surgery should be done at that time...

Also, although it is generally believed that there are four types of myopia surgery, if we divide them according to technology, there are actually two types of myopia surgery, laser myopia surgery and ICL lens implantation, which are addition and subtraction.

Laser myopia surgery is subtraction, and it is also irreversible. Its problems are different from lens implants, and if you feel bad about lens implants, you can take them out..."

At this point, Gan Yuntao talked about the myopia surgery from beginning to end, and at the end, Zhou Ming really had a deep and comprehensive understanding of this aspect.

"How about the field of myopia surgery in China? If biotech companies want to get involved in this field in the future, does Dr. Gan have any suggestions?"

After Gan Yuntao finished speaking, Zhou Ming asked again.

"It turns out that Professor Zhou wants to get involved in the field of myopia surgery? However, this may not be an easy task."

Hearing Zhou Ming's question, Gan Yuntao realized that Zhou Ming wanted Future Biotech to get involved in the field of myopia surgery, but when he said this, Gan Yuntao's face was both surprised and curious.

"Why do you say that? Can Dr. Gan explain it in detail?" Zhou Ming asked again.

"It depends on how your company wants to enter this industry. If it's really pure myopia surgery, the most expensive thing for an institution is actually the machine, and an ordinary topographic map costs hundreds of thousands.

For a decent refractive center, there is no 4000-[-] million that cannot be achieved, and you need to be equipped with some full femtosecond machines or something.

What's more important, you know? "

As soon as he said this, Gan Yuntao's expression was obviously different from before, and now he looked even more excited.

"I don't know, what is it?" Zhou Ming also asked Gan Yuntao sensibly.

"If you don't have technology, you can only be controlled by others.

Those manufacturers of medical equipment are very good at doing business, but it doesn’t mean that a machine is sold to you for a few million and it’s over. Even if you spend so much money on the machine, they still have to control your subsequent use.

The use of those machines requires a password, so every time you use it, you can only ask them to send you a password, and you can't do it without a password.

Your future biotechnology company is quite big, and your annual profit is already quite a lot, right?
Is the money earned in this field of myopia surgery less than those of your company’s new projects?How did you come up with the idea of ​​getting involved in this field?
If you really want to engage in the field of myopia surgery, you have to buy machines from others, and most of the money you earn will be collected by those medical device manufacturers. This is not like your company's style. I remember your company was founded It has always been about innovation. "

Gan Yuntao said to Zhou Ming, and after saying this, when he said the rest, his voice became obviously quieter, and there was some curiosity and mystery on his face.

This is why Gan Yuntao is curious. As a newly emerging company that is now involved in almost all biological fields, Future Biotechnology Company has many people paying attention to him.

Gan Yuntao naturally also pays attention to the situation of this company. After all, the eye is also in the field of biology. Who knows if this company will get involved in the future?

As a top ophthalmologist in China, he naturally has to keep an eye on this development.

If biotechnology companies really set foot in the field of ophthalmology in the future, it will be a matter of concern to ophthalmologists. Maybe that day the world will change in this field.

Now Zhou Ming came to him personally to consult with him about this matter, and also asked about Future Biotechnology Engineering's involvement in this field. Gan Yuntao felt that his previous concern for Future Biotechnology Company was not wrong. They really only need to work with Future Biotechnology Company. Biologically related fields are covered.

"Is your company planning to research some new technology for the treatment of myopia?"

If other people came to consult him, Gan Yuntao would not think about it, but it was Zhou Ming who came to him and asked clearly if his company was involved in this field, then Gan Yuntao would naturally think about it.

It's not Gan Yuntao's fault, who made Future Biotech have a lot of achievements in the field of biotechnology this year.

Although these successes have not yet been put into the market due to time constraints.

"It turns out that there is such a saying. I said why these surgeries are so expensive. It turns out that the cost is high."

After hearing Gan Yuntao's words, Zhou Ming showed a suddenly realized expression, nodded seriously, and murmured.

Like full femtoseconds, the price is generally between 1.5 and 2.5, while for ICL implantation, the price is generally between 3 and 3.5.

"Dr. Gan, you guessed it right, our company really wants to research technologies for the treatment of myopia.

In fact, before I came here, I checked the current number of myopic people in Huaguo. I was a little surprised by the results. In a few years, the number of myopic people in China will reach half of the total number of people in China.

This is far beyond my expectation. I know that there are many people who are short-sighted, but I didn't expect there to be so many, so I want to get involved in this field, so that the domestic short-sighted people can have more choices in the future. "

Zhou Ming explained to Gan Yuntao.

"Yes, with the increasing workload of students and the popularization of mobile phones and computers, the number of myopic people in China has indeed increased a lot in the past two years.

In fact, the number of myopia people is increasing not only in China but also around the world.

Can you tell me how your company plans to get involved in this field? "

Gan Yuntao asked Zhou Ming that he had been doing research in this area for some years, and he really couldn't think of any breakthrough and innovative treatment methods, so he was also very curious about what kind of method Zhou Ming and his biotechnology company would come up with in the future. .

“Actually, before I came here, I didn’t even have a definite idea.

However, after listening to what you said, I do have some ideas now, but these ideas are not innovations. I just want to make some reforms based on the existing myopia surgery.

Forget about laser-type surgeries like full femtosecond and half femtosecond, we don’t plan to get involved here, after all, we don’t have the technology in this area yet in terms of related machine manufacturing.

The phakic posterior chamber intraocular lens implantation you mentioned earlier, its principle is to implant a foldable intraocular lens into the eye, which is actually equivalent to wearing long-term contact lenses for the eyes to achieve the purpose of vision correction .

However, since it is an implant method and a foreign thing, it must have some hidden dangers to the eyes, the human body itself may reject it, and there is also the possibility of infection. More than ten years.

I just thought that the reason why ICL lens implantation has so many disadvantages is that it is a crystal material containing collagen. Although it has good biocompatibility, it is not a biological material after all.

If we replace the implanted crystal with a biological material that can adapt well to the human body, can these disadvantages be avoided? "

Zhou Ming told Gan Yuntao what was in his heart.

"It's not like no one has thought of your idea, but with the current technology, it may be difficult to realize."

Originally, Gan Yuntao thought that a person like Zhou Ming must have some amazing ideas, but now he heard Zhou Ming say this, but he was a little disappointed.

"I set up a cloning experiment group this year, and I think my group may be able to provide some support for this technology.

Based on genetic technology, we can clone the same biological material as the human cornea. "

Zhou Ming continued to explain to Gan Yuntao.

"Your cloning team is about to produce results?"

When Zhou Ming's cloning team was recruiting people, Gan Yuntao also knew about it. The industry originally thought that even if Zhou Ming's experimental team wanted to produce results, it would probably take at least several years to get preliminary results.

Hearing what Zhou Ming said now, Gan Yuntao thought they would produce results so soon, so he also showed a very shocked expression on his face.

"The results are coming soon, but it's still too early to realize complete organ cloning.

What I mean is that the technique of cloning organs is used to produce biomaterials like the human cornea, which is more convenient and simpler than cloning a complete organ using somatic cells.

I just don’t know what Dr. Gan thinks about this matter?After all, you have been working in the field of myopia for so many years, so you must know more than a layman like me. "

Zhou Ming said.

This time, Gan Yuntao did not show his disappointed expression like before. If what Zhou Ming said can be realized, changing the ICL crystal implantation technology to a transparent version of artificial cornea material implantation technology, this is really a big deal for myopia patients the gospel.

Although it is a foreign object, the implanted material is a biological material, and it is cultivated through the patient's own gene cloning, so there is no problem of rejection, and there will be no infection.

"If your cloning technology can really do this, it's not impossible.

However, if you really succeed, I am afraid that many manufacturers in this field will hate it to death, haha. "

Gan Yuntao said to Zhou Ming with an expression of interest on his face.

If what Zhou Ming said can be done, then those in the field of myopia surgery will no longer need to use foreign instruments. According to the products that biotechnology companies have released, their company is still very conscientious.

And he, Gan Yuntao, is not a scholar or a doctor, and he does not produce medical equipment. When Zhou Ming's words are really going to come true, he will just change medical equipment.

(End of this chapter)